By Counterforce Health Team in Photrexa (riboflavin ophthalmic solution) —

How to Get Photrexa (Riboflavin) Covered by Humana in Illinois: Coding, Appeals & Prior Authorization Guide

Answer Box: Getting Photrexa Covered by Humana in Illinois

Photrexa (riboflavin ophthalmic solution) requires prior authorization from Humana for corneal collagen cross-linking in progressive keratoconus or corneal ectasia. The fastest path to approval: 1) Use correct codes (ICD-10 H18.62x for unstable keratoconus, HCPCS J2787 x2 units, CPT 0402T), 2) Document disease progression with serial Kmax and pachymetry values, and 3) Submit through Humana's provider portal with complete clinical notes. Start today by gathering your corneal topography reports showing progression and contacting your ophthalmologist to initiate the prior authorization request. If denied, you have 65 days to appeal, with Illinois external review available within 4 months.

Table of Contents

  1. Coding Basics: Medical vs. Pharmacy Benefit Paths
  2. ICD-10 Mapping for Keratoconus and Corneal Ectasia
  3. Product Coding: HCPCS, J-Codes, and NDC Requirements
  4. Clean Prior Authorization Request Anatomy
  5. Frequent Coding Pitfalls to Avoid
  6. Verification with Humana Resources
  7. Quick Audit Checklist
  8. Appeals Playbook for Illinois
  9. Common Denial Reasons & Solutions
  10. FAQ

Coding Basics: Medical vs. Pharmacy Benefit Paths

Photrexa (riboflavin ophthalmic solution) for corneal collagen cross-linking typically falls under the medical benefit, not pharmacy. This is crucial because:

  • Medical benefit: Covers the procedure (CPT 0402T) and drug (J2787) as part of an in-office treatment
  • Pharmacy benefit: Would only apply if Photrexa were dispensed for home use (which it isn't—it's physician-administered)

The distinction matters for Humana coverage because medical benefit claims require different prior authorization forms and have different appeal pathways than pharmacy benefit denials.

Note: Always verify with Humana whether your specific plan processes Photrexa under medical or pharmacy benefits, as some Medicare Advantage plans have unique structures.

ICD-10 Mapping for Keratoconus and Corneal Ectasia

Accurate ICD-10 coding is essential for Photrexa approval. Humana requires documentation of progressive disease to justify cross-linking therapy.

Primary Diagnosis Codes

ICD-10 Code Description Documentation Required
H18.621 Keratoconus, unstable, right eye Serial Kmax increase ≥1.0D in 12 months
H18.622 Keratoconus, unstable, left eye Pachymetry thinning ≥20μm over 12 months
H18.623 Keratoconus, unstable, bilateral Evidence of visual acuity decline
H18.59 Other corneal deformities (ectasia) Post-surgical ectasia documentation

Documentation Words That Support Coding

When your ophthalmologist documents your condition, these specific terms strengthen your case:

  • "Progressive keratoconus" or "unstable keratoconus"
  • "Kmax increased from X to Y diopters"
  • "Corneal thinning documented on pachymetry"
  • "Worsening best-corrected visual acuity"
  • "Failed conservative management"
Tip: Request copies of all your corneal topography reports. Serial measurements showing progression are the strongest evidence for medical necessity.

Product Coding: HCPCS, J-Codes, and NDC Requirements

Essential Codes for Photrexa Cross-Linking

Procedure Code:

  • CPT 0402T: Collagen cross-linking of cornea (includes epithelial removal and pachymetry)

Drug Code:

  • HCPCS J2787: Riboflavin 5'-phosphate, ophthalmic solution, up to 3 mL
  • Units: 2 units per procedure (6 mL total required)

NDC Code:

  • 25357-0025-03 (11-digit format required by most carriers)

Units Calculation

The math is straightforward but critical:

  • Each procedure requires 6 mL of riboflavin solution
  • J2787 covers "up to 3 mL"
  • Therefore: Bill 2 units of J2787 per eye treated

When Modifiers Apply

  • -RT: Right eye
  • -LT: Left eye
  • -50: Bilateral procedure (if both eyes treated same day)

Clean Prior Authorization Request Anatomy

Here's what a complete Humana prior authorization request should include:

Required Elements Checklist

Patient Information:

  • Humana member ID
  • Patient demographics
  • Treating ophthalmologist details

Clinical Documentation:

  • Primary diagnosis: H18.62x (unstable keratoconus)
  • Serial corneal topography reports
  • Pachymetry measurements over time
  • Visual acuity trends
  • Failed conservative treatments

Procedure Details:

  • CPT 0402T (cross-linking procedure)
  • J2787 x2 (riboflavin solution)
  • NDC 25357-0025-03
  • Planned facility/site of service

Medical Necessity Statement:

  • Disease progression documentation
  • Treatment goals and expected outcomes
  • FDA-approved indication confirmation

Frequent Coding Pitfalls to Avoid

Common Mistakes That Trigger Denials

  1. Using stable keratoconus codes (H18.61x) instead of unstable (H18.62x)
  2. Billing only 1 unit of J2787 instead of the required 2 units
  3. 10-digit NDC format instead of 11-digit (25357-025-03 vs. 25357-0025-03)
  4. Missing progression documentation in clinical notes
  5. Bundling incompatible codes (don't report 0402T with 65435, 69990, or 76514)

Unit Conversion Errors

Remember: Photrexa procedures require 6 mL total

  • ❌ Wrong: 1 unit J2787 (only covers 3 mL)
  • ✅ Correct: 2 units J2787 (covers full 6 mL needed)

Verification with Humana Resources

Pre-Submission Verification Steps

  1. Check formulary status: Use Humana's drug list tool to verify J2787 coverage
  2. Verify prior authorization requirements: Call provider services at the number on your member ID
  3. Confirm facility network status: Ensure your ophthalmologist and surgery center are in-network
  4. Review medical policy: Search for "corneal collagen cross-linking" in Humana's provider manual

Cross-Check Your Codes

Before submitting, verify:

  • ICD-10 code matches documented disease state
  • HCPCS J2787 is current (effective January 1, 2019)
  • NDC format is 11-digit
  • Units calculation is correct (2 units for bilateral, 2 units per eye)

Quick Audit Checklist

Pre-Submission Review

Documentation Review:

  • Progressive keratoconus clearly documented
  • Serial measurements show worsening
  • Conservative treatments attempted/failed
  • FDA-approved indication confirmed

Coding Review:

  • H18.62x (unstable) not H18.61x (stable)
  • J2787 x2 units calculated correctly
  • NDC in 11-digit format
  • No incompatible code combinations

Administrative Review:

  • Prior authorization submitted before treatment
  • All required forms completed
  • Supporting documents attached
  • Provider and facility in-network

Appeals Playbook for Illinois

If Humana denies your Photrexa prior authorization, Illinois provides strong appeal rights with specific timelines.

Internal Appeal (First Level)

Timeline: You have 65 days from denial notice to file Decision timeframe: Humana must decide within 7 calendar days for Part D appeals How to file: Online portal, phone (number on member ID), or written appeal

External Review (Independent Review)

If internal appeal fails, Illinois law guarantees external review by an independent physician reviewer.

Timeline: 30 days from final internal denial (shorter than many states) Cost: Free to you (Illinois insurers pay IRO fees) Reviewer qualifications: Board-certified ophthalmologist with keratoconus expertise Decision timeframe: 5 business days after IRO receives all materials

Illinois-Specific Resources

  • Illinois Department of Insurance: (877) 527-9431
  • External Review Forms: Available at idoi.illinois.gov
  • Attorney General Health Helpline: (877) 305-5145

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
"Not medically necessary" Submit progression data Serial Kmax/pachymetry showing worsening
"Experimental/investigational" Cite FDA approval FDA labeling for progressive keratoconus
"Non-formulary drug" File formulary exception Prescriber letter explaining medical necessity
"Incorrect coding" Verify all codes Use H18.62x, J2787 x2, CPT 0402T
"Missing prior authorization" Resubmit with PA Complete prior auth before treatment

Medical Necessity Letter Components

Your ophthalmologist's letter should include:

  1. Diagnosis: Progressive keratoconus with ICD-10 code
  2. Disease progression: Specific Kmax and pachymetry changes
  3. Failed treatments: Contact lenses, glasses insufficient
  4. Treatment rationale: FDA-approved indication
  5. Expected outcomes: Corneal stabilization, vision preservation

FAQ

How long does Humana prior authorization take for Photrexa in Illinois? Standard requests: up to 30 days. Expedited requests (if urgent): 72 hours. Submit early to avoid delays.

What if Photrexa is non-formulary on my Humana plan? File a formulary exception with your prescriber's supporting statement. Humana must respond within 72 hours for standard requests.

Can I request an expedited appeal if my keratoconus is worsening rapidly? Yes. If delay would seriously jeopardize your health, request expedited review (24-hour decision timeline).

Does step therapy apply to Photrexa cross-linking? Typically yes—you'll need to document failed conservative treatments (glasses, contact lenses) before approval.

What happens if I get cross-linking without prior authorization? You may be responsible for the full cost ($2,500-$4,000 per eye). Always get approval first.

How do I find an in-network ophthalmologist for cross-linking in Illinois? Use Humana's provider directory and filter for ophthalmologists. Call to confirm they perform cross-linking procedures.

Can I appeal if my cross-linking was done out-of-network? Yes, but you'll need to demonstrate medical necessity and lack of in-network alternatives.

What if my appeal is denied by Humana? File for Illinois external review within 30 days. An independent ophthalmologist will review your case.

When navigating complex prior authorizations and appeals, having expert support can make the difference between approval and denial. Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements, pulling the right clinical evidence and procedural details that payers expect.

For patients facing Photrexa denials, Counterforce Health can help identify the specific denial basis—whether it's missing progression documentation, incorrect coding, or formulary issues—and create compelling appeals that address Humana's exact coverage criteria. This targeted approach reduces the back-and-forth that often delays treatment approval.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Coverage policies and procedures may change; verify current requirements with Humana and Illinois state resources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.